BridgeMD
New treatment option for Schizophrenia
Official title The Effect of Game-Based Intervention on the Cognition of Schizophrenia Patients
ClinicalTrials.gov ID: NCT07557381
What this study is testing
- What it's testing
- Schizophrenia is a common and severe mental disorder that imposes a significant burden on patients. Cognitive impairment can be regarded as one of the core symptoms of schizophrenia, which is prevalent among patients with schizophrenia.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45
You may be able to join if
- Registered in the Shanghai Mental Health Information Management System and hospitalized in the designated district-level mental health center wards;
- Schizophrenia patients meeting the diagnostic criteria of schizophrenia in the International Classification of Diseases (ICD-10);
- 18 - 45 years old;
- Good self-care ability;
- Clinically stable (without acute exacerbation) for at least 1 week before enrollment, with a stable dose of antipsychotic drugs or other concomitant...
You likely can't join if
- not reside in Shanghai after discharge;
- suffering from serious physical or brain organic diseases;
- comorbid with other psychotic disorders.
See the full eligibility criteria
- Registered in the Shanghai Mental Health Information Management System and hospitalized in the designated district-level mental health center wards;
- Schizophrenia patients meeting the diagnostic criteria of schizophrenia in the International Classification of Diseases (ICD-10);
- 18 - 45 years old;
- Good self-care ability;
- Clinically stable (without acute exacerbation) for at least 1 week before enrollment, with a stable dose of antipsychotic drugs or other concomitant psychotropic drugs for at least 1 week;
- No hand disabilities, and can use mobile phones or tablets normally;
- Have a primary school education or above;
- Normal vision and hearing, or within the normal range after correction;
- Own and be able to independently use a smart phone or other electronic devices;
- Patients and their families have given informed consent to this study, and voluntarily cooperate to participate in the intervention and sign the informed consent form.
- not reside in Shanghai after discharge;
- suffering from serious physical or brain organic diseases;
- comorbid with other psychotic disorders.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.